Literature DB >> 19401370

Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome.

Harry J Hirsch1, Talia Eldar-Geva, Fortu Benarroch, Orit Rubinstein, Varda Gross-Tsur.   

Abstract

BACKGROUND: Recent studies challenge the assumption that hypogonadism in Prader-Willi syndrome (PWS) is due only to hypothalamic dysfunction.
OBJECTIVES: The aims of the study were to characterize sexual development and reproductive hormones in PWS males and investigate the etiology of hypogonadism.
METHODS: Physical examination and blood sampling were performed on 37 PWS males, ages 4 months to 32 yr.
RESULTS: All had a history of undescended testes; age at orchiopexy ranged from 2 months to 6 yr. Pubertal signs were variable, but none achieved full genital development. Anti-Mullerian hormone (AMH) levels in PWS boys were near the lower limits of normal, decreasing from 44.4 +/- 17.8 ng/ml (mean +/- sd) in young children to 5.9 +/- 4.7 ng/ml in adolescents, similar to normal males. In contrast, inhibin B was consistently low (27.1 +/- 36.1 pg/ml) or undetectable in all age groups. In adult males, FSH levels were high (20.3 +/- 18.3 IU/liter), LH levels were normal (4.2 +/- 4.3 IU/liter), and testosterone levels were low (1.87 +/- 1.17 ng/ml). Only two adults had severe hypogonadotropic hypogonadism with undetectable levels of LH and FSH and high AMH levels (34.9 and 36.7 ng/ml), unlike the other nine adults with AMH levels 2.6 +/- 2.1 ng/ml. Androstenedione (1.06 +/- 0.30 ng/ml) and DHEAS (281.1 +/- 143.6 microg/dl) in adult PWS were normal.
CONCLUSIONS: Pubertal development in PWS is characterized by normal adrenarche, variable hypothalamic dysfunction, and hypogonadism due to a unique testicular defect. Primary testicular dysfunction is a major component of hypogonadism in PWS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401370     DOI: 10.1210/jc.2008-2760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Review of Prader-Willi syndrome: the endocrine approach.

Authors:  Ryan Heksch; Manmohan Kamboj; Kathryn Anglin; Kathryn Obrynba
Journal:  Transl Pediatr       Date:  2017-10

2.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

Review 3.  Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Authors:  Rasmus Sode-Carlsen; Stense Farholt; Kai Fr Rabben; Jens Bollerslev; Thomas Schreiner; Anne Grethe Jurik; Jens Sandahl Christiansen; Charlotte Höybye
Journal:  Endocrine       Date:  2011-11-12       Impact factor: 3.633

Review 4.  Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.

Authors:  Giovanna Muscogiuri; Gloria Formoso; Gabriella Pugliese; Rosaria Maddalena Ruggeri; Elisabetta Scarano; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

5.  Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.

Authors:  Jennifer L Miller; Tiffany D Linville; Elisabeth M Dykens
Journal:  J Pediatr Endocrinol Metab       Date:  2014-01       Impact factor: 1.634

6.  Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.

Authors:  T N Hangartner; D F Short; T Eldar-Geva; H J Hirsch; M Tiomkin; A Zimran; V Gross-Tsur
Journal:  Osteoporos Int       Date:  2016-07-04       Impact factor: 4.507

7.  The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction.

Authors:  Varda Gross-Tsur; Harry J Hirsch; Fortu Benarroch; Talia Eldar-Geva
Journal:  Reprod Biol Endocrinol       Date:  2012-05-06       Impact factor: 5.211

Review 8.  Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys.

Authors:  Romina P Grinspon; Nazareth Loreti; Débora Braslavsky; Clara Valeri; Helena Schteingart; María Gabriela Ballerini; Patricia Bedecarrás; Verónica Ambao; Silvia Gottlieb; María Gabriela Ropelato; Ignacio Bergadá; Stella M Campo; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-07       Impact factor: 5.555

9.  CENTRAL PRECOCIOUS PUBERTY IN TWO BOYS WITH PRADER-WILLI SYNDROME ON GROWTH HORMONE TREATMENT.

Authors:  Elena Monai; Anders Johansen; Erik Clasen-Linde; Ewa Rajpert-De Meyts; Niels Erik Skakkebæk; Katharina M Main; Anne Jørgensen; Rikke Beck Jensen
Journal:  AACE Clin Case Rep       Date:  2019-08-15

10.  Prader-willi syndrome: clinical aspects.

Authors:  Grechi Elena; Cammarata Bruna; Mariani Benedetta; Di Candia Stefania; Chiumello Giuseppe
Journal:  J Obes       Date:  2012-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.